| 1 |
PAPAIOANNOU A I, MAZIOTI A, KIROPOULOS T, et al. Systemic and airway inflammation and the presence of emphysema in patients with COPD[J]. Respiratory Medicine, 2010, 104(2): 275-282.
|
| 2 |
LABAKI W W, ROSENBERG S R. Chronic obstructive pulmonary disease[J]. Annals of Internal Medicine, 2020, 173(3): ITC17-ITC32.
|
| 3 |
ISAAC R, REIS F C G, YING W, et al. Exosomes as mediators of intercellular crosstalk in metabolism[J]. Cell Metabolism, 2021, 33(9): 1744-1762.
|
| 4 |
KHATRI M, RICHARDSON L A, MEULIA T. Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model[J]. Stem Cell Research and Therapy, 2018, 9(1): 17.
|
| 5 |
AHN S Y, PARK W S, KIM Y E, et al. Vascular endothelial growth factor mediates the therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicles against neonatal hyperoxic lung injury[J]. Experimental and Molecular Medicine, 2018, 50(4): 1-12.
|
| 6 |
KAUR G, MAREMANDA K P, CAMPOS M, et al. Distinct exosomal miRNA Profiles from BALF and Lung Tissue of COPD and IPF patients[J]. International Journal of Molecular Sciences, 2021, 22(21): 11830.
|
| 7 |
KALLURI R, LEBLEU V S. The biology, function, and biomedical applications of exosomes[J]. Science, 2020, 367(6478): eaau6977.
|
| 8 |
ZHANG Y, LIU Y, LIU H, et al. Exosomes: biogenesis, biologic function and clinical potential[J]. Cell and Bioscience, 2019, 15(9): 19.
|
| 9 |
VLASSOV A V, MAGDALENO S, SETTERQUIST R, et al. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials[J]. Biochimica et Biophysica Acta, 2012, 1820(7): 940-948.
|
| 10 |
RAPOSO G, STOORVOGEL W. Extracellular vesicles: exosomes, microvesicles, and friends[J]. The Journal of Cell Biology, 2013, 200(4): 373-383.
|
| 11 |
KOSAKA N, IGUCHI H, YOSHIOKA Y, et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells[J]. The Journal of Biological Chemistry, 2010, 285(23): 17442-17452.
|
| 12 |
JAENISCH R, BIRD A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals[J]. Nature Genetics, 2003, 33 Suppl: 245-254.
|
| 13 |
GUAN S, LI Q, LIU P, et al. Umbilical cord blood-derived dendritic cells loaded with BGC823 tumor antigens and DC-derived exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumor immunity in vitro and in vivo[J]. Central-European Journal of Immunology, 2014, 39(2): 142-151.
|
| 14 |
MULCAHY L A, PINK R C, CARTER D R. Routes and mechanisms of extracellular vesicle uptake[J]. Journal of Extracellular Vesicles. 2014, 3.
|
| 15 |
GURUNG S, PEROCHEAU D, TOURAMANIDOU L, et al. The exosome journey: from biogenesis to uptake and intracellular signalling[J]. Cell Communication and Signaling: CCS, 2021, 19(1): 47.
|
| 16 |
LÄSSER C, O'NEIL S E, SHELKE G V, et al. Exosomes in the nose induce immune cell trafficking and harbour an altered protein cargo in chronic airway inflammation[J]. Journal of Translational Medicine, 2016, 14(1): 181.
|
| 17 |
PINNELL J R, CUI M, TIEU K. Exosomes in Parkinson disease[J]. Journal of Neurochemistry, 2021, 157(3): 413-428.
|
| 18 |
WANG B, ZHANG A, WANG H, et al. MiR-26a limits muscle wasting and cardiac fibrosis through exosome-mediated microRNA transfer in chronic Kidney disease[J]. Theranostics, 2019, 9(7): 1864-1877.
|
| 19 |
JEFFRIES J, ZHOU W, HSU A Y, et al. MiRNA-223 at the crossroads of inflammation and cancer[J]. Cancer Letters, 2019, 451: 136-141.
|
| 20 |
MOHAN A, AGARWAL S, CLAUSS M, et al. Extracellular vesicles: novel communicators in lung diseases[J]. Respiratory Research, 2020, 21(1): 175.
|
| 21 |
BENEDIKTER B J, WOUTERS E F M, SAVELKOUL P H M, et al. Extracellular vesicles released in response to respiratory exposures: implications for chronic disease[J]. Journal of Toxicology and environmental health, Part B, Critical reviews, 2018, 21(3): 142-160.
|
| 22 |
VESTBO J, HURD S S, AGUSTÍ A G, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary[J]. American Journal of Respiratory and Critical Care Medicine. 2013, 187(4): 347-365.
|
| 23 |
LOWE K E, REGAN E A, ANZUETO A, et al. COPDGene® 2019: redefining the diagnosis of chronic obstructive pulmonary disease[J]. Chronic Obstructive Pulmonary Diseases, 2019, 6(5): 384-399.
|
| 24 |
CERVERI I, CORSICO A G, ACCORDINI S, et al. Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes[J]. Thorax, 2008, 63(12): 1040-1045.
|
| 25 |
JUNG A L, MØLLER JØRGENSEN M, BÆK R, et al. Surface proteome of plasma extracellular vesicles as biomarkers for pneumonia and acute exacerbation of chronic obstructive pulmonary disease[J]. The Journal of Infectious Diseases, 2020, 221(2): 325-335.
|
| 26 |
TAKAHASHI T, KOBAYASHI S, FUJINO N, et al. Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility[J]. Thorax, 2012, 67(12): 1067-1074.
|
| 27 |
TAN D B A, ARMITAGE J, TEO T H, et al. Elevated levels of circulating exosome in COPD patients are associated with systemic inflammation[J]. Respiratory Medicine, 2017 , 132: 261-264.
|
| 28 |
LI C J, LIU Y, CHEN Y, et al. Novel proteolytic microvesicles released from human macrophages after exposure to tobacco smoke[J]. The American Journal of Pathology, 2013, 182(5): 1552-1562.
|
| 29 |
LETSIOU E, SAMMANI S, ZHANG W, et al. Pathologic mechanical stress and endotoxin exposure increases lung endothelial microparticle shedding[J]. American Journal of Respiratory Cell and Molecular Biology, 2015, 52(2): 193-204.
|
| 30 |
HÉLIOT A, LANDKOCZ Y, ROY SAINT-GEORGES F, et al. Smoker extracellular vesicles influence status of human bronchial epithelial cells[J]. International Journal of Hygiene and Environmental Health, 2017, 220(2 Pt B): 445-454.
|
| 31 |
KAUR G, MAREMANDA K P, CAMPOS M, et al. Distinct exosomal miRNA profiles from BALF and Lung Tissue of COPD and IPF Patients[J]. International Journal of Molecular Sciences, 2021, 22(21): 11830.
|
| 32 |
MOON H G, KIM S H, GAO J, et al. CCN1 secretion and cleavage regulate the lung epithelial cell functions after cigarette smoke[J]. American Journal of Physiology. Lung Cellular and Molecular Physiology, 2014, 307(4): L326-337.
|
| 33 |
WANG L, CHEN Q, YU Q, et al. Cigarette smoke extract-treated airway epithelial cells-derived exosomes promote M1 macrophage polarization in chronic obstructive pulmonary disease[J]. International Immunopharmacology, 2021, 96: 107700.
|
| 34 |
ZHU Z, LIAN X, SU X, et al. Exosomes derived from adipose-derived stem cells alleviate cigarette smoke-induced lung inflammation and injury by inhibiting alveolar macrophages pyroptosis[J]. Respiratory Research, 2022, 23(1): 5.
|
| 35 |
ZOU Y, BHAT O M, YUAN X, et al. Release and actions of inflammatory exosomes in pulmonary emphysema: potential therapeutic target of acupuncture[J]. Journal of Inflammation Research, 2021, 14: 3501-3521.
|
| 36 |
KIM Y S, CHOI J P, KIM M H, et al. IgG sensitization to extracellular vesicles in indoor dust is closely associated with the prevalence of non-eosinophilic asthma, COPD, and lung cancer[J]. Allergy Asthma and Immunology Research, 2016, 8(3): 198-205.
|
| 37 |
YANG J, KIM E K, PARK H J, et al. The impact of bacteria-derived ultrafine dust particles on pulmonary diseases[J]. Experimental and Molecular Medicine, 2020, 52(3): 338-347.
|
| 38 |
KIM Y S, LEE W H, CHOI E J, et al. Extracellular vesicles derived from gram-negative bacteria, such as escherichia coli, induce emphysema mainly via IL-17A-mediated neutrophilic inflammation[J]. The Journal of Immunology : Official Journal of the American Association of Immunologists, 2015, 194(7): 3361-3368.
|
| 39 |
王秋实. SP--D基因缺陷小鼠肺部病理和免疫改变及外泌体干预对肺修复作用的研究[D]. 济南: 山东大学, 2019.
|
| 40 |
KIM Y S, KIM J Y, CHO R, et al. Adipose stem cell-derived nanovesicles inhibit emphysema primarily via an FGF2-dependent pathway[J]. Experimental and Molecular Medicine, 2017, 49(1): e284.
|
| 41 |
GENSCHMER K R, RUSSELL D W, LAL C, et al. Activated PMN exosomes: pathogenic entities causing matrix destruction and disease in the Lung[J]. Cell, 2019, 176(1-2): 113-126. e15.
|
| 42 |
FUJITA Y, ARAYA J, ITO S, et al. Suppression of autophagy by extracellular vesicles promotes myofibroblast differentiation in COPD pathogenesis[J]. Journal of Extracellular Vesicles, 2015, 4: 28388.
|
| 43 |
XU H, LING M, XUE J, et al. Exosomal microRNA-21 derived from bronchial epithelial cells is involved in aberrant epithelium-fibroblast cross-talk in COPD induced by cigarette smoking[J]. Theranostics, 2018, 8(19): 5419-5433.
|
| 44 |
HE S, CHEN D, HU M, et al. Bronchial epithelial cell extracellular vesicles ameliorate epithelial-mesenchymal transition in COPD pathogenesis by alleviating M2 macrophage polarization[J]. Nanomedicine, 2019, 18: 259-271.
|
| 45 |
TrialsClinical. National Library of Medicine; U.S: Gov. Exosome | respiratory diseases[EB/OL]. [2023-2-21].
URL
|
| 46 |
TrialsClinical. National Library of Medicine; U.S: 2020. Gov. Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes (CSET 1437) [EB/OL]. [2023-2-21].
URL
|
| 47 |
VIAUD S, PLOIX S, LAPIERRE V, et al. Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferon-γ[J]. Journal of Immunotherapy, 2011, 34(1): 65-75.
|
| 48 |
BESSE B, CHARRIER M, LAPIERRE V, et al. Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC[J]. Oncoimmunology, 2015, 5(4): e1071008.
|
| 49 |
SENGUPTA V, SENGUPTA S, LAZO A, et al. Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19[J]. Stem Cells and Development, 2020, 29(12): 747-754.
|
| 50 |
TrialsClinical. National Library of Medicine; U.S: 2020. Gov. Evaluation of safety and efficiency of method of exosome inhalation in SARS-CoV-2 associated pneumonia (COVID-19EXO)[EB/OL]. [2023-2-21].
URL
|
| 51 |
SHI M M, YANG Q Y, MONSEL A, et al. Preclinical efficacy and clinical safety of clinical-grade nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesicles[J]. Journal of Extracellular Vesicles, 2021, 10(10): e12134.
|
| 52 |
Clinical Trials. National Library of Medicine; U.S: 2020. Gov. The Individualized accurate diagnosis and treatment of chronic objective pulmonary disease(COPD) aPtients based on multidimensional data (COPD)[EB/OL]. [2023-2-21].
URL
|